THERANOSTICS 2016* Peter Roselt
Peter MacCallum Cancer Centre, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Optimised production of 64Cu-SARTATE for a phase 1 clinical trial (#4)
11:00 AM
Charmaine Jeffery
Refining and Defining NET Targets (submitted abstracts)
A fully automated synthesis for the preparation of 64,67Cu-SARTATE using the iPHASE MultiSyn Radiosynthesiser (#69)
8:30 AM
Charmaine Jeffery
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours